Trial intelligence / Profile preview

Propofol MCT/LCT formulation comparison in periampullary carcinoma patients undergoing Whipple procedure

ChiCTR-TRC-12002627Phase 4Completed

Sponsor
Beijing Chaoyang Hospital
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol in Periampullary Carcinoma (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Plasma triglyceride concentration. Started Sep 2014; status: completed.

02

Drugs

propofol
03

Conditions

Periampullary Carcinoma

Beyond the preview

Go deeper on ChiCTR-TRC-12002627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call